- Home
- CLLS vs PHD Comparison
CLLS vs PHD Comparison
Compare CLLS & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- PHD
- Stock Information
- Founded
- CLLS 1999
- PHD 2004
- Country
- CLLS France
- PHD United States
- Employees
- CLLS N/A
- PHD N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- CLLS Health Care
- PHD Finance
- Exchange
- CLLS Nasdaq
- PHD Nasdaq
- Market Cap
- CLLS 144.4M
- PHD 120.3M
- IPO Year
- CLLS 2007
- PHD N/A
- Fundamental
- Price
- CLLS $1.49
- PHD $9.77
- Analyst Decision
- CLLS Buy
- PHD
- Analyst Count
- CLLS 3
- PHD 0
- Target Price
- CLLS $6.67
- PHD N/A
- AVG Volume (30 Days)
- CLLS 46.6K
- PHD 67.7K
- Earning Date
- CLLS 05-12-2025
- PHD 01-01-0001
- Dividend Yield
- CLLS N/A
- PHD 11.43%
- EPS Growth
- CLLS N/A
- PHD N/A
- EPS
- CLLS N/A
- PHD 1.27
- Revenue
- CLLS $54,747,000.00
- PHD N/A
- Revenue This Year
- CLLS $48.52
- PHD N/A
- Revenue Next Year
- CLLS $5.17
- PHD N/A
- P/E Ratio
- CLLS N/A
- PHD $7.60
- Revenue Growth
- CLLS 351.26
- PHD N/A
- 52 Week Low
- CLLS $1.10
- PHD $8.30
- 52 Week High
- CLLS $2.78
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- CLLS 51.15
- PHD 66.55
- Support Level
- CLLS $1.46
- PHD $9.70
- Resistance Level
- CLLS $1.60
- PHD $9.78
- Average True Range (ATR)
- CLLS 0.08
- PHD 0.06
- MACD
- CLLS -0.01
- PHD -0.01
- Stochastic Oscillator
- CLLS 52.17
- PHD 86.67
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.